Show Summary Details
Page of

Hepatitis B reactivation 

Hepatitis B reactivation
Hepatitis B reactivation

Gayatri Chakrabarty

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 May 2022

There is a significant risk of relapse with chronic hepatitis B during periods of immunosuppression. Prophylaxis with antiretroviral agents has the potential to prevent relapse and complications such as liver fibrosis, and is strongly supported in the hepatology community and through professional guidelines. A case is presented where the patient was not offered prophylaxis despite risk factors and suffered a significant relapse after chemotherapy for malignancy. The testing, management, and treatment of hepatitis B are discussed with particular attention to the role of prophylaxis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.